SK Capital Partners (SK Capita), a private investment firm focused on the specialty materials, has completed the previously announced sale of IBA Molecular (IBAM) to funds advised by private equity firm CapVest Partners.
IBA Molecular was jointly owned by SK Capital and Ion Beam Applications S.A. prior to the sale. Terms of the transaction were not disclosed.
Since SK Capital acquired 60 per cent of IBA Molecular in April 2012, the Company has successfully executed on a number of operational improvement initiatives and strategic transactions. Jamshid Keynejad, Founding Partner of SK Capital, says: “The Company’s leading position in its core markets provided a solid foundation for growth, while the efforts of Renaud Dehareng and his team, alongside support from SK Capital, helped drive the Company’s exceptional performance. We congratulate the IBA Molecular team on their accomplishments and wish the team and their new owners every success in the future.”
Rothschild Inc. served as exclusive financial advisor and Morgan, Lewis & Bockius LLP served as legal counsel to SK Capital for the transaction.
